Comparative Evaluation of ^sup 18^F-FDG PET and ^sup 67^Ga Scintigraphy in Patients with Sarcoidosis

From: The Journal of Nuclear Medicine | Date: October 1, 2006| Author: Et al; Fukunaga, Kotaro; Takinami, Hiroyuki; Yamamoto, Yuka; Nishiyama, Yoshihiro | Copyright information

^sup 67^Ga scintigraphy has been used for years in sarcoidosis for diagnosis and the extent of the disease. However, little information is available on the comparison of ^sup 18^F-FDG PET and ^sup 67^Ga scintigraphy in the assessment of sarcoidosis. The purpose of this study was to compare the uptake of ^sup 18^F-FDG and ^sup 67^Ga in the evaluation of pulmonary and extrapulmonary involvement in patients with sarcoidosis. Methods: Eighteen patients with sarcoidosis were examined. ^sup 18^F-FD...

Related newspaper, magazine, and journal articles from HighBeam Research

^sup 18^F-FLT PET for Visualization of Laryngeal Cancer: Comparison with ^sup 18^F-FDG PET
The Journal of Nuclear Medicine ; The feasibility of ^sup 18^F-3'-fluoro-3'-deoxy-L-thymidine PET (FLT PET) for detecting laryngeal cancer was investigated and compared with ^sup 18^F-FDG PET. Methods: Eleven patients diagnosed with or strongly suspected of having recurrent laryngeal cancer and 10 patients with histologically
Is ^sup 18^F-3'-Fluoro-3'-Deoxy-L-Thymidine Useful for the Staging and Restaging of Non-Small Cell Lung Cancer?
The Journal of Nuclear Medicine ; The objective of this study was to compare ^sup 18^F-3'-fluoro-3'-deoxy-L-thymidine (FLT) PET with clinical TNM staging, including that by ^sup 18^F-FDG PET, in patients with non-small cell lung cancer (NSCLC). Methods: Patients with NSCLC underwent whole-body ^sup 18^F-FDG PET and whole-body ^sup
Usefulness of Fasting ^sup 18^F-FDG PET in Identification of Cardiac Sarcoidosis
The Journal of Nuclear Medicine ; Cardiac PET using ^sup 18^F-FDG under fasting conditions (fasting ^sup 18^F-FDG PET) is a promising technique for identification of cardiac sarcoidosis and assessment of disease activity. The aim of this study was to investigate the usefulness of fasting ^sup 18^F-FDG PET in detecting inflammatory
Comparison of ^sup 18^F-FDG PET and Bone Scintigraphy in Detection of Bone Metastases of Thyroid Cancer
The Journal of Nuclear Medicine ; We compared the efficacies of ^sup 18^F-FDG PET and ^sup 99m^Tc-bone scintigraphy for the detection of bone metastases in patients with differentiated thyroid carcinoma (DTC). Methods: We examined 47 patients (32 women, 15 men; mean age SD, 57.0 10.7 y) with DTC who had undergone total
^sup 18^F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: A meta-analysis
The Journal of Nuclear Medicine ; PET using ^sup 18^F-FDG is increasingly used for the diagnosis and grading of tumors. Several studies have been performed that evaluate the diagnostic and grading performance of ^sup 18^F-FDG PET for soft-tissue sarcoma, but each study has had a limited sample size. Therefore, we undertook a
Small-Animal PET of Melanocortin 1 Receptor Expression Using a ^sup 18^F-Labeled [alpha]-Melanocyte-Stimulating Hormone Analog
The Journal of Nuclear Medicine ; ^sup 18^F-Labeled small synthetic peptides have emerged as attractive probes for imaging various molecular targets with PET. The α-melanocyte-stimulating hormone 945;-MSH) receptor (melanocortin type 1 receptor [MC1R]) is overexpressed in most murine and human melanomas. It is a promising
Imaging Proliferation in Lung Tumors with PET: ^sup 18^F-FLT Versus ^sup 18^F-FDG
The Journal of Nuclear Medicine ; Recently, the thymidine analog 3'-deoxy-3sup 18^F-fluorothymidine (FLT) was suggested for imaging tumoral proliferation. In this prospective study, we examined whether ^sup 18^F-FLT better determines proliferative activity in newly diagnosed lung nodules than does ^sup 18^F-FDG. Methods: Twenty-six
PET with 0-(2-^sup 18^F-Fluoroethyl)-L-Tyrosine in Peripheral Tumors: First Clinical Results
The Journal of Nuclear Medicine ; O-(2-^sup 18^F-Fluoroethyl)-L-Tyrosine (^sup 18^F-FET) PET has shown promising results in brain tumor diagnosis. The aim of this prospective study was to evaluate ^sup 18^F-FET PET in comparison with ^sup 18^F-FDG PET in patients with peripheral tumors. Methods: Forty-four consecutive patients with
^sup 18^F-Fluoroacetate: A Potential Acetate Analog for Prostate Tumor Imaging-In Vivo Evaluation of ^sup 18^F-Fluoroacetate Versus ^sup 11^C-Acetate
The Journal of Nuclear Medicine ; PET with ^sup 11^C-acetate (^sup 11^C-ACE) has a high sensitivity for detection of prostate cancer and several other cancers that are poorly detected with ^sup 18^F-FDG. However, the short half-life (20.4 min) of ^sup 11^C limits the general availability of ^sup 11^C-ACE. ^sup 18^F-Fluoroacetate
^sup 18^F-FDG PET for Evaluation of the Treatment Response in Patients with Gastrointestinal Tract Lymphomas
The Journal of Nuclear Medicine ; ^sup 18^F-FDG PET is highly sensitive and specific for evaluation of the treatment response of nodal and extranodal diseases in patients with malignant lymphomas. However, no data are available in the literature with regard to ^sup 18^F-FDG PET for evaluation of the treatment response in patients